Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2004 May;27(5):258-64.
doi: 10.1002/clc.4960270503.

Lipoprotein(a): new insights into mechanisms of atherogenesis and thrombosis

Arjun Deb  1 , Noel M Caplice
Affiliations
Review

Lipoprotein(a): new insights into mechanisms of atherogenesis and thrombosis

Arjun Deb et al. Clin Cardiol. 2004 May.

Abstract

Lipoprotein(a) (Lp[a]) continues to be a controversial molecule regarding its role in human vascular disease. Although the physiologic role of this molecule is still unclear, novel discoveries within the last few years have suggested numerous mechanisms whereby Lp(a) may contribute to atherosclerosis and its complications in human subjects. These effects may differentially occur in vascular tissue and circulating blood compartments. A complex interplay between tissue-specific effects is probably more relevant to the pathogenicity of this molecule than one single effect alone. This review briefly describes the structure of Lp(a) in relation to its biochemical function, summarizing the current literature on various pathophysiologic mechanisms of Lp(a)-induced vascular disease and the role of cell and tissue-specific effects in promoting atherogenesis and thrombosis.

PubMed Disclaimer

References

    1. Scanu AM: Atherothrombogenicity of lipoprotein(a): The debate. Am J Cardiol 1998; 82: 26Q–33Q - PubMed
    1. Albers JJ, Adolphson JL, Hazzard WR: Radioimmunoassay of human plasma Lp(a) lipoprotein. J Lipid Res 1977; 18: 331–338 - PubMed
    1. Dahlen G, Berg K, Gillnas T, Ericson C: Lp(a) lipoprotein/pre‐beta1‐lipo‐protein in Swedish middle‐aged males and in patients with coronary heart disease. Clin Genet 1975; 7: 334–341 - PubMed
    1. Dahlen G, Ericson C, Furberg C, Lundkvist L, Svardsudd K: Studies on an extra pre‐beta lipoprotein fraction. Acta Med Scand 1972; 531 (suppl): 1–29 - PubMed
    1. Ridker PM, Hennekens CH, Stampfer MJ: A prospective study of lipoprotein(a) and the risk of myocardial infarction (see comments). J Am Med Assoc 1993; 270: 2195–2199 - PubMed

MeSH terms